About Us
Products
Infectious Disease Antigens
Chlamydiaceae
Cytomegalovirus
Dengue
Hepatitis
Herpesvirus and EBV
Measles, Mumps and Varicella
Respiratory Antigens
Rotavirus
Rubella
Product List: Infectious Disease Antigens
Proficiency Testing
New products/ Announcements
Adenovirus Vectors
AdMax™
AdCre
AdMax™ Hi-IQ
Helper Dependent Adenovirus
Ordering Adenovirus
Adenovirus Price List
Water Based Products
Water For Injection
USP Purified Water
Custom Solutions and Buffers
Pipeline
LumiSort™
Urokinase
VIRUSMAX
Investors
Contact
Site Map
About Us
Contact
Home
Investors
Board of Directors
Financial Reports
Ordering Information
International Distributors
Product Inquiry
Pipeline
LumiSort™
Lumisort Contacts
LumiSort™ For Farmers
LumiSort™ Semen Sexing Technology for the AI Industry
LumiSort™ Technology
Urokinase
VIRUSMAX™
Products
Adenovirus Vectors
AdMax™
AdCre
Adenovirus Price List
AdMax™ Hi-IQ
Helper Dependent Adenovirus
Maps and Sequences
Ordering Adenovirus
Technical Support
Infectious Disease Antigens
Chlamydiaceae
Cytomegalovirus
Dengue
FAQ
Hepatitis
Herpesvirus and EBV
Measles, Mumps and Varicella
Product List: Infectious Disease Antigens
Respiratory Antigens
Rotavirus
Rubella
Proficiency Testing
Water Based Products
Custom Solutions and Buffers
USP Purified Water
Water For Injection
Quality Assurance
Site Map
Newsroom
Microbix’ LumiSort® Patent Withstands Competitive Challenge
Microbix Reports Very Strong First Quarter Results
Microbix and Zydus Cadila Reach Agreement to Market Urokinase, A Critical Care Therapy In North America
Microbix Reports 2011 Results
Microbix Closes Previously Announced Equity Offering for Gross Proceeds of $448,231
Events
Annual General Meeting: Thursday, March 8, 2012 at 1:00 PM
28th Clinical Virology Symposium: April 20-25, 2012, Daytona Beach, FL
AACC: July 17-19, 2012 Los Angeles, CA
MEDICA: Düsseldorf, Germany Nov. 14-17, 2012
